NEXT DX Trademark

Trademark Overview


On Tuesday, October 4, 2022, a trademark application was filed for NEXT DX with the United States Patent and Trademark Office. The USPTO has given the NEXT DX trademark a serial number of 97619159. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Personalis, Inc.. The NEXT DX trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment

Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
next dx

General Information


Serial Number97619159
Word MarkNEXT DX
Filing DateTuesday, October 4, 2022
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7302826
Registration DateTuesday, February 13, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Description of MarkThe mark consists of NEXT DX with the X in NEXT formed by a shape resembling a part of a DNA helix.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAnalysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
NOT AVAILABLE"DX"
Goods and ServicesProviding genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code042
First Use Anywhere DateMonday, September 26, 2022
First Use In Commerce DateMonday, September 26, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code044
First Use Anywhere DateSunday, September 11, 2022
First Use In Commerce DateSunday, September 11, 2022

Trademark Owner History


Party NamePersonalis, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NamePersonalis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NamePersonalis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Friday, October 7, 2022NEW APPLICATION ENTERED
Thursday, October 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 18, 2023ASSIGNED TO EXAMINER
Tuesday, July 25, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 25, 2023NON-FINAL ACTION E-MAILED
Tuesday, July 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED